Diversified Trust CO Palatin Technologies Inc Transaction History

Diversified Trust CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Jan 08, 2021	SELL	$0.38 - $0.78 $20,007 - $41,067	-52,650 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$0.47 - $0.64 $24,745 - $33,696	52,650 New	52,650 $25,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $17.5M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.